DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Kasichayanula S, Chang M, Hasegawa M. et al.
Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium-glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus.
Diabetes Obes Metab 2011;
13: 357-365
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.